What are the guidelines for screening asymptomatic individuals for Mycoplasma genitalium in a primary care setting?

Current guidelines do not recommend routine screening of asymptomatic individuals for Mycoplasma genitalium in a primary care setting. The focus is on targeted testing based on symptoms or risk factors rather than universal screening.

Screening and testing strategies emphasise offering a range of STI testing options, including remote self-sampling and in-person attendance, tailored to local needs and individual preferences. However, these recommendations primarily address common STIs and do not specifically endorse screening asymptomatic people for Mycoplasma genitalium.

Interventions should be culturally sensitive, non-judgemental, and inclusive, ensuring people have autonomy over their sexual health decisions. Testing should be accessible and offered especially to groups with greater sexual health or access needs, but routine screening for Mycoplasma genitalium in asymptomatic individuals is not indicated.

Partner notification and referral pathways to specialist sexual health services are important components of managing diagnosed STIs, but these apply after diagnosis rather than for screening asymptomatic individuals.

In summary, current UK guidelines focus on targeted testing and improving access and uptake of STI testing generally, without recommending routine screening for Mycoplasma genitalium in asymptomatic people in primary care.

References: ¹